This Symposium will be hosted live and available on-demand
November 17-18, 2026
11:00 AM - 3:00 PM ET
Advances in high-throughput omics technologies are transforming biomedical research by enabling comprehensive analyses of genomes, transcriptomes, proteomes, metabolomes, and epigenomes. As researchers increasingly integrate these datasets with spatial biology and computational approaches, multiomics is providing new opportunities to understand disease mechanisms, identify therapeutic targets, and accelerate biomarker discovery across translational research.
In this symposium, leading researchers will discuss how multiomics approaches are advancing therapeutic innovation across drug discovery and precision medicine. Sessions will explore emerging technologies in genomics, transcriptomics, proteomics, metabolomics, epigenomics, and spatial biology while highlighting strategies for integrating complex datasets to improve biological understanding, support biomarker discovery, and accelerate translational research.
Topics to be covered:
- Integrating genomics, transcriptomics, proteomics, metabolomics, and epigenomics
- Spatial omics approaches for understanding tissue biology
- Multiomics strategies for biomarker discovery and target validation
- Computational methods for analyzing complex biological datasets
- Applications of multiomics in drug discovery and precision medicine
- Emerging technologies shaping the future of therapeutic innovation
 | Luigi Prisco |
 | Jeremy Lambert |
 | Arjun Krishnan |
 | Katrin Schönborn, PhD |
